SGI Venture Capital

Dime Bio is a drug development company for novel dementia treatments.

Airbility is a company specializing in the development of innovative aircraft components for the aviation and aerospace sectors. It focuses on creating electric aircraft solutions that leverage optimized geometry, vertical take-off and landing capabilities, distributed fanjet systems, and modular hybrid energy propulsion. Airbility's flagship product, the AB-2, is a two-seat manned aircraft designed to meet the MOSAIC rule, aiming to provide safe and quiet medium to long-distance travel.

Soomvi is a company focused on the industrial drone market, specializing in marine lifesaving system services. It develops advanced drones that are engineered to enhance safety and performance through the integration of sophisticated technology. These drones feature a sensor-isolated and vibration-resistant structural design, enabling reliable operation in demanding environments. They are equipped with capabilities for real-time synchronization and communication of flight information, along with a backup control system for added safety. Soomvi's innovations aim to meet the needs of various industrial applications, enhancing operational efficiency while ensuring security.

Lookinsight is a solution to solve the problems of the pharmaceutical distribution industry.

Novelty Nobility Inc. is a private biotech company dedicated to researching novel angiogenesis targets and developing antibody-based therapeutics, particularly in the fields of ophthalmology and oncology. The company has identified Stem Cell Factor (SCF) and c-KIT as significant angiogenesis targets, which are linked to the proliferation and survival of hematopoietic stem cells. By focusing on the anti-SCF/c-KIT pathway, Novelty Nobility aims to address the unmet medical needs associated with existing anti-VEGF treatments, specifically regarding efficacy and long-term safety. The company is actively engaged in developing therapeutic antibodies and antibody-drug conjugates to combat drug resistance and the negative effects of aberrant blood vessel growth in conditions such as retinal diseases and solid tumors. Their lead candidate, NN2101, a full-human monoclonal antibody, is currently in preclinical development and is supported by strong patent protection in the United States and South Korea.

Unastella is a company focused on the development and operation of its own launch vehicles, specifically designed to provide human space travel services. It specializes in creating civilian manned space launch vehicles that facilitate quasi-orbital space travel. By advancing technology for safe and reliable manned space flights, Unastella aims to enable passengers to experience space travel in a quasi-orbital environment.

Vueron is a technology company focused on enhancing safety through advanced LiDAR solutions tailored for automotive and industrial applications. The company develops AI-based perception software that effectively identifies various objects surrounding the sensor while utilizing minimal computing resources. Vueron's innovative platform is designed for immediate integration with Advanced Driver Assistance Systems (ADAS) and autonomous driving systems, providing critical information on elements such as lanes, guardrails, and potential hazards. Additionally, Vueron's technology supports Internet of Things (IoT) applications, including security and smart city initiatives. By collaborating with automotive OEMs, Tier-1 suppliers, and other industry stakeholders, Vueron aims to deliver practical and cost-effective LiDAR perception products that meet the diverse needs of its clients.

PineTree Therapeutics is a biotechnology company focused on developing innovative therapies in the fields of oncology and immuno-oncology. The company specializes in creating biological therapeutics that address unmet medical needs, particularly in treating solid tumors and infectious diseases. Utilizing advanced technologies, including tumor-associated essential receptor-targeting antibodies and virus-targeting recombinant agents, PineTree Therapeutics aims to empower healthcare professionals in the development of effective anticancer treatments. Through its commitment to addressing critical health challenges, the company seeks to enhance patient outcomes in the oncology landscape.

Gwanak Analog is a company specializing in the design and supply of high-performance power and analog system-on-chip (SoC) and sensor products. It focuses on creating analog and power semiconductors for various applications, including industrial, telecommunications, automotive, and consumer sectors. By leveraging advanced power semiconductor design technology alongside digital signal processing techniques, Gwanak Analog aims to enhance power efficiency in its products. The company’s innovations help clients reduce overall energy consumption in their systems, providing environmentally sustainable and compact solutions.

CnerG, pronounced as "synergy," is a company focused on facilitating clean energy solutions to help corporations achieve carbon neutrality and meet their renewable energy commitments. It operates a cross-border platform for Environmental Commodities, including Energy Attribute Certificates and carbon credits, catering to global corporations engaged in the voluntary clean energy market. CnerG's marketplace streamlines the procurement of these commodities from over 80 countries, while also offering a range of Software as a Service (SaaS) solutions. These solutions include contract management, market intelligence, and continuous audit capabilities, all supported by CnerG Chain, the company's proprietary blockchain technology. The platform emphasizes decentralized power purchase agreement transactions, enhancing data management, settlements, and secondary trading of renewable energy certificates, thereby increasing operational efficiency and reducing transaction costs for buyers and sellers in the clean energy sector.

VEStellaLab is a provider of advanced AI-based navigation solutions focused on enhancing parking experiences for drivers and autonomous vehicles. The company offers innovative indoor navigation services, including WatchMile, which assists drivers in locating optimal parking spots by using cutting-edge indoor positioning technology and vision AI recognition. This system not only identifies available parking spaces in real time but also guides users to their selected locations, effectively addressing common challenges such as congestion and inefficient parking. By leveraging proprietary technologies that convert CAD files into lighter digital maps and employing precise positioning algorithms, VEStellaLab aims to streamline the parking process, providing significant value in smart city initiatives and the evolving landscape of autonomous transportation.

Chemtopia is a consulting firm focused on chemical safety, environmental health, and ESG compliance. The company offers a range of services, including risk assessment, product consulting, and chemical substance management, to assist businesses in adhering to regulatory standards and mitigating chemical risks. Chemtopia combines its expertise with advanced IT solutions, providing smart EHS platforms that leverage AI and IoT technologies to enhance workplace safety and improve environmental performance. By delivering high-quality environmental testing and analysis, Chemtopia enables clients to achieve their sustainability goals effectively.

VSI is a manufacturer of semiconductors specializing in automotive networking technologies. The company develops essential networking solutions aimed at next-generation automotive and industrial applications, with a particular focus on supporting the needs of autonomous vehicles. By providing innovative products that enhance vehicle connectivity, VSI plays a crucial role in advancing the automotive industry and meeting the demands of modern car manufacturers.

Tradlinx is a developer and provider of an end-to-end supply chain management platform that enhances global logistics operations through improved visibility and connectivity. The company's technology aims to address longstanding challenges in the logistics market by offering reliable tracking solutions, including bill of lading and vessel tracking, as well as comprehensive data insights to optimize supply chain decisions. Recognized as a leading freight management solution provider in the Asia Pacific region, Tradlinx focuses on customer feedback to continuously enhance its services. The company's ultimate objective is to create an Integrated Platform Ecosystem that connects all aspects of logistics, enabling international shippers to access vital information and streamline their operations from origin to final destination.

PineTree Therapeutics is a biotechnology company focused on developing innovative therapies in the fields of oncology and immuno-oncology. The company specializes in creating biological therapeutics that address unmet medical needs, particularly in treating solid tumors and infectious diseases. Utilizing advanced technologies, including tumor-associated essential receptor-targeting antibodies and virus-targeting recombinant agents, PineTree Therapeutics aims to empower healthcare professionals in the development of effective anticancer treatments. Through its commitment to addressing critical health challenges, the company seeks to enhance patient outcomes in the oncology landscape.

Novelty Nobility Inc. is a private biotech company dedicated to researching novel angiogenesis targets and developing antibody-based therapeutics, particularly in the fields of ophthalmology and oncology. The company has identified Stem Cell Factor (SCF) and c-KIT as significant angiogenesis targets, which are linked to the proliferation and survival of hematopoietic stem cells. By focusing on the anti-SCF/c-KIT pathway, Novelty Nobility aims to address the unmet medical needs associated with existing anti-VEGF treatments, specifically regarding efficacy and long-term safety. The company is actively engaged in developing therapeutic antibodies and antibody-drug conjugates to combat drug resistance and the negative effects of aberrant blood vessel growth in conditions such as retinal diseases and solid tumors. Their lead candidate, NN2101, a full-human monoclonal antibody, is currently in preclinical development and is supported by strong patent protection in the United States and South Korea.

Triz is a commerce platform that focuses on the beauty and healthcare sectors, providing a comprehensive marketing solution for businesses in these industries. The company offers a range of services, including commercial management, brand publishing, original equipment manufacturing and design, brand distribution, tax assistance, and corporate social responsibility support. By integrating these services into a systematic framework, Triz aims to help firms maximize their sales potential and achieve sustainable growth. Additionally, Triz seeks to create a new commerce and influencer ecosystem featuring differentiated products, enhancing the overall experience for both brands and consumers.

VEStellaLab is a provider of advanced AI-based navigation solutions focused on enhancing parking experiences for drivers and autonomous vehicles. The company offers innovative indoor navigation services, including WatchMile, which assists drivers in locating optimal parking spots by using cutting-edge indoor positioning technology and vision AI recognition. This system not only identifies available parking spaces in real time but also guides users to their selected locations, effectively addressing common challenges such as congestion and inefficient parking. By leveraging proprietary technologies that convert CAD files into lighter digital maps and employing precise positioning algorithms, VEStellaLab aims to streamline the parking process, providing significant value in smart city initiatives and the evolving landscape of autonomous transportation.

Angel Robotics is a technology company specializing in the research, development, manufacturing, and sale of intelligent wearable robotic devices designed to assist individuals with disabilities. Their product line includes the angel MEDI, a wearable robot focused on rehabilitation medicine; the angel GEAR, an industrial wearable robot; the angel SUIT, which provides daily life assistance; and the angel KIT, which comprises core components like motor drivers and smart actuators. In addition to these consumer-facing products, Angel Robotics also engages in research and development services aimed at creating wearable robots for defense applications.

Wiju is a company that specializes in integrated marketing solutions, focusing on revitalizing traditional and local markets. It has developed a digital marketing platform that offers mobile advertising services specifically tailored for traditional markets in Korea. By facilitating direct communication with consumers through mobile platforms, Wiju enables its clients in the local commercial sectors to effectively promote their businesses and engage with local consumers, ultimately helping them generate income and enhance their market presence.

Master Meditech Inc. is a biotechnology company based in Seoul, South Korea, specializing in the development of new pharmaceuticals through protein structure identification and medicinal chemistry. Established in 2019, the company focuses on leveraging advanced scientific techniques to discover innovative drug candidates, aiming to address various medical needs. With a commitment to enhancing therapeutic options, Master Meditech is positioned at the intersection of technology and healthcare, striving to contribute to advancements in the pharmaceutical industry.

Biobab AiBIO is a biotechnology company focused on drug development through the application of artificial intelligence. The company specializes in bio-space voyager technology, which enhances the efficiency of drug discovery, particularly for patients suffering from intractable and rare diseases. By leveraging cryogenic electron microscopy (cryo-EM), Biobab AiBIO addresses the limitations of traditional X-ray crystallography, allowing for detailed analysis of the three-dimensional structures of novel target proteins. This advanced approach enables the identification and development of new drugs aimed at innovative therapeutic targets, positioning Biobab AiBIO at the forefront of biopharmaceutical advancements.

ATsens is a healthcare technology company focused on improving cardiac health diagnostics. It operates a healthcare platform designed to enhance the diagnostic capabilities of professionals by developing a compact, lightweight, and energy-efficient patch-type electrocardiograph. This device allows users to monitor and detect heart issues efficiently, utilizing minimal resources.

PeLeMed is a drug development company dedicated to discovering and developing anti-cancer therapies aimed at treating patients with incurable cancers and intractable carcinomas. The company employs a type 1 kinase inhibitor development platform to create innovative therapeutic candidates. This platform not only focuses on oncology but also has potential applications in treating neurological and immune diseases. By advancing its drug discovery efforts, PeLeMed seeks to extend patient survival and improve treatment outcomes for challenging medical conditions.

Macaron M is a mobile application that specializes in providing taxi services, focusing on scheduled car reservations. The platform allows users to reserve vehicles through a straightforward calling system as well as through the app, which offers a selection of various vehicle options. Macaron M aims to enhance the travel experience by simplifying the payment process and offering discounts, making it easier for customers to plan their journeys in advance.

FireVisor Systems Pte. Ltd., founded in 2018 and based in Singapore, offers an AI-powered software platform that transforms the manufacturing sector by leveraging previously untapped data. The company focuses on automating manufacturing processes to enhance efficiency and quality control. By utilizing artificial intelligence and machine learning, FireVisor's platform detects, analyzes, and monitors defects in production, thereby minimizing the reliance on human inspectors and process control engineers. This innovative approach aims to create self-aware factories that can autonomously optimize operations, reducing costs associated with poor quality and increasing overall profitability for clients. In a global manufacturing industry valued at $17.2 trillion, FireVisor seeks to harness the vast amounts of data generated by machines to drive significant enhancements in productivity and operational effectiveness.

Medi Futures is a company specializing in the development and manufacture of advanced ultrasonic technology platforms for biomedical firms. Their product portfolio includes enzyme-free ultrasound stem cell separators and ultrasonic endoscopic disc surgical equipment. These solutions are designed to enhance surgical outcomes by providing surgeons with access to ultrasonic and biological fusion medical technologies, which reduce incision size, procedure time, and patient pain. The company's innovations cater to both cosmetic and surgical applications, making them a notable player in the field of minimally invasive medical procedures.

weneepl is a blockchain game development company.

Insignary, Inc. is a South Korean company founded in 2016, specializing in binary-level software composition analysis. The firm develops innovative software and cloud-based solutions that enable advanced scanning of open source software binaries to identify and mitigate security vulnerabilities and compliance issues. Utilizing a unique fingerprint-based technology, Insignary's solutions operate without requiring source code or reverse engineering, allowing clients to proactively scan their software binaries for known security risks. The company's executive team possesses extensive experience in the IT industry, particularly in open source software, compliance, and security, positioning Insignary as a leader in the field.

WATCHA, Inc. is a South Korean company founded in 2011 and headquartered in Seoul, specializing in online interactive media services. It initially gained popularity as a movie review application, becoming a favorite in Korea for its personalized recommendation technology. Users rate movies, allowing WATCHA to predict their preferences for unseen films. In addition to its review platform, WATCHA launched a subscription video-on-demand service called WATCHA PLAY in 2016, which offers a wide selection of movies and TV series accessible across various devices, including web browsers, mobile platforms, and smart TVs. The service is noted for its highly accurate content recommendations, with a significant portion of consumed content driven by these suggestions. WATCHA has also expanded its presence internationally, having launched in Japan in 2015.